Authors:
Ozdemir, V
Kalow, W
Okey, AB
Lam, MSM
Albers, LJ
Reist, C
Fourie, J
Posner, P
Collins, EJ
Roy, R
Citation: V. Ozdemir et al., Treatment-resistance to clozapine in association with ultrarapid CYP1A2 activity and the C -> A polymorphism in intron 1 of the CYP1A2 gene: Effect of grapefruit juice and low-dose fluvoxamine, J CL PSYCH, 21(6), 2001, pp. 603-607
Authors:
Ozdemir, V
Kalow, W
Posner, P
Collins, EJ
Kennedy, JL
Tang, BK
Albers, LJ
Reist, C
Roy, R
Walkes, W
Afra, P
Citation: V. Ozdemir et al., CYP1A2 activity as measured by a caffeine test predicts clozapine and active metabolite norclozapine steady-state concentration in patients with schizophrenia, J CL PSYCH, 21(4), 2001, pp. 398-407
Authors:
Maile, R
Wang, B
Schooler, W
Meyer, A
Collins, EJ
Frelinger, JA
Citation: R. Maile et al., Antigen-specific modulation of an immune response by in vivo administration of soluble MHC class I tetramers, J IMMUNOL, 167(7), 2001, pp. 3708-3714
Authors:
Urvater, JA
Hickman, H
Dzuris, JL
Prilliman, K
Allen, TM
Schwartz, KJ
Lorentzen, D
Shufflebotham, C
Collins, EJ
Neiffer, DL
Raphael, B
Hildebrand, W
Sette, A
Watkins, DI
Citation: Ja. Urvater et al., Gorillas with spondyloarthropathies express an MHC class I molecule with only limited sequence similarity to HLA-B29 that binds peptides with arginine at P2, J IMMUNOL, 166(5), 2001, pp. 3334-3344
Authors:
Sharma, AK
Kuhns, JJ
Yan, SQ
Friedline, RH
Long, B
Tisch, R
Collins, EJ
Citation: Ak. Sharma et al., Class I major histocompatibility complex anchor substitutions alter the conformation of T cell receptor contacts, J BIOL CHEM, 276(24), 2001, pp. 21443-21449
Authors:
Mylin, LM
Schell, TD
Roberts, D
Epler, M
Boesteanu, A
Collins, EJ
Frelinger, JA
Joyce, S
Tevethia, SS
Citation: Lm. Mylin et al., Quantitation of CD8(+) T-lymphocyte responses to multiple epitopes from simian virus 40 (SV40) large T antigen in C57BL/6 mice immunized with SV40, SV40 T-antigen-transformed cells, or vaccinia virus recombinants expressing full-length T antigen or epitope minigenes, J VIROLOGY, 74(15), 2000, pp. 6922-6934
Authors:
Marzo, AL
Kinnear, BF
Lake, RA
Frelinger, JJ
Collins, EJ
Robinson, BWS
Scott, B
Citation: Al. Marzo et al., Tumor-specific CD4(+) T cells have a major "post-licensing" role in CTL mediated anti-tumor immunity, J IMMUNOL, 165(11), 2000, pp. 6047-6055
Authors:
Serody, JS
Collins, EJ
Tisch, RM
Kuhns, JJ
Frelinger, JA
Citation: Js. Serody et al., T cell activity after dendritic cell vaccination is dependent on both the type of antigen and the mode of delivery, J IMMUNOL, 164(9), 2000, pp. 4961-4967
Authors:
Wang, B
Maile, R
Greenwood, R
Collins, EJ
Frelinger, JA
Citation: B. Wang et al., Naive CD8(+) T cells do not require costimulation for proliferation and differentiation into cytotoxic effector cells, J IMMUNOL, 164(3), 2000, pp. 1216-1222
Authors:
Batalia, MA
Kirksey, TJ
Sharma, A
Jiang, LH
Abastado, JP
Yan, SQ
Zhao, R
Collins, EJ
Citation: Ma. Batalia et al., Class I MHC is stabilized against thermal denaturation by physiological concentrations of NaCl, BIOCHEM, 39(30), 2000, pp. 9030-9038
Authors:
Gibbens, RJ
Whittle, P
Ansell, P
Bather, J
Collins, EJ
Gittins, J
Zervos, M
Bauerle, N
Birge, JR
Frostig, E
Weiss, G
McDiarmid, C
Mohring, RH
Uetz, M
Schulz, AS
Owen, RW
Gregorio-Dominguez, MM
Preater, J
Rieder, U
Stidham, S
Thomas, L
Yao, DD
Citation: Rj. Gibbens et al., The achievable region approach to the optimal control of stochastic systems - Discussion, J ROY STA B, 61, 1999, pp. 776-791
Citation: Ej. Collins et al., Extensive alanine substitutions increase binding affinity of an influenza nucleoprotein peptide to HLA-Aw68 and do not abrogate peptide-specific CTL recognition, J IMMUNOL, 162(1), 1999, pp. 331-337
Authors:
Kirksey, TJ
Pogue-Caley, RR
Frelinger, JA
Collins, EJ
Citation: Tj. Kirksey et al., The structural basis for the increased immunogenicity of two HIV-reverse transcriptase peptide variant/class I major histocompatibility complexes, J BIOL CHEM, 274(52), 1999, pp. 37259-37264
Authors:
Kuhns, JJ
Batalia, MA
Yan, SQ
Collins, EJ
Citation: Jj. Kuhns et al., Poor binding of a HER-2/neu epitope (GP2) to HLA-A2.1 is due to a lack of interactions with the center of the peptide, J BIOL CHEM, 274(51), 1999, pp. 36422-36427